{
  "meta": {
    "title": "Neet_Pg_2022",
    "url": "https://brainandscalpel.vercel.app/neet-pg-2022-3b762051.html",
    "scrapedAt": "2025-11-30T07:35:34.425Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Ciliary staphyloma</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Scleromalacia perforans </span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Coloboma</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Staphyloma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient comes with history of rheumatoid arthritis and ocular finding as showing in this image. What is the diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/2025042128ea197e-b339-4458-a2ff-f35a6260fea7.jpg\"></span></p>",
      "unique_key": "DT1323527",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323527,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Dry Eye Syndrome</strong></p>\n<p>Dry eye syndrome, also known as keratoconjunctivitis sicca, is the most com&shy;mon ocular manifestation of RA. It can occur as a result of meibomian gland, lacrimal gland, accessory lacrimal gland, or goblet cell dysfunction.</p>\n<p>Characteristics. Symptoms of dry eye syndrome include foreign body sensation, burning, decreased visual acuity, photophobia, and pruritus.</p>\n<p>Diagnostic signs include less than 5 mm of tear extension on Schirmer's test, tear break-up time of 5 seconds or less, decreased lacrimal lake, and stain&shy;ing with fluorescein, rose bengal, or lissamine green.1 Up to 25% of patients with RA meet criteria for secondary Sj&ouml;gren syndrome, which is less com&shy;monly associated with xerostomia than is primary Sj&ouml;gren syndrome. Notably, different HLA genes are associated with primary Sj&ouml;gren syndrome and Sj&ouml;gren syndrome secondary to RA.2 Addition&shy;ally, the prevalence of positive anti-Ro antibodies and anti-La antibodies is low in patients with RA, found in one study to be 12.2% and 11.3%, respec&shy;tively.</p>\n<p>Other considerations. The normal tear film has antimicrobial properties and contains immunomodulatory factors such as collagenase inhibitors (e.g., alpha-2 macroglobulin). Patients with dry eye syndrome are deficient in these protective mechanisms and have increased proteolytic enzymes such as plasminogen activator in the tear film.4 Consequentially, dry eye syndrome can lead to superficial punctate keratitis, filamentary keratitis, corneal ulcer, and ultimately, corneal melt.1 Accordingly, RA is a relative contraindication against refractive surgery, especially LASIK, due to its potential to exacerbate dry eye syndrome.4 (See also \"Surgical Consid&shy;erations in RA Ocular Disease.\")</p>\n<p>Treatment. Therapeutic modalities include lubricating drops and ointments, topical cyclosporine, and oral pilocarpine. The recent approval of lifitegrast has added a new medication to our armamentarium of topical treat&shy;ments. In-office procedures include punctal occlusion, use of amniotic membrane, and tarsorrhaphy.</p>\n<p><strong>Episcleritis</strong></p>\n<p>Episcleritis is inflammation of the epis&shy;clera, which lies just beneath Tenon&rsquo;s capsule. Although the disorder is usu&shy;ally idiopathic, it can also be associated with RA and other systemic diseases. It is bilateral 40% of the time, and man&shy;ifests with salmon-pink eyes and mild pain. It can occur sectorally in a radial distribution; in a diffuse pattern; and, less commonly, in a nodular form. In contrast to scleritis, eye redness resolves with topical phenylephrine.</p>\n<p>Treatment. Episcleritis is usually self-limiting. Topical corticosteroids or oral nonsteroidal anti-inflammatory drugs (NSAIDs) can be used for symp&shy;tomatic relief.</p>\n<p><strong>Scleritis</strong></p>\n<p>RA is the most common cause of scleri&shy;tis, which is an inflammation of the sclera characterized by vasodilation of the superficial and deep episcleral ves&shy;sels. Occasionally, scleritis may present before the onset of joint symptoms in the RA patient. It may also occur as a manifestation of systemic vasculitis. Scleritis occurs bilaterally 40% to 50% of the time and is classified as anterior or posterior based on its position rela&shy;tive to the ora serrata.</p>\n<p>Types of scleritis. Anterior scleritis can be nodular, diffuse, or necrotizing. It usually presents with intense pain amplified by eye movements, blurry vi&shy;sion, photophobia, and tearing.</p>\n<p><strong>Scleromalacia perforans</strong> describes anterior necrotizing scleritis without inflammation. This condition often presents without pain, despite its ability to lead to visual loss, astigma&shy;tism, and globe perforation.</p>\n<p>Posterior scleritis is characterized by the \"T\" sign on B-scan. This classic sign is produced by hyporeflectivity from both the optic nerve and fluid under Tenon's capsule.</p>\n<p>Anterior Scleritis</p>\n<p>Other considerations. The pres&shy;ence of scleritis in patients with RA is associated with increased mortality.1 Posterior scleritis can cause serous ret&shy;inal detachment or chorioretinal folds. Other sequelae associated with scleritis include uveitis, cataracts, glaucoma, posterior segment damage, and periph&shy;eral ulcerative keratitis.</p>\n<p>Treatment. Topical medications are generally not effective in the treatment of scleritis. Therapy should focus on managing the underlying RA, with a multidisciplinary team approach involving the patient's primary care physician and rheumatologist. Oral NSAIDs are most effective in mild cases and for nodular anterior scleritis.</p>\n<p>For more severe disease, the treat&shy;ment of choice is oral corticosteroids (1 mg/kg/day of prednisone equiva&shy;lents), with an optional bolus of methylprednisolone 1 g daily for 3 days.</p>\n<p>Depending on response and severity of scleritis at presentation, additional systemic medications include metho&shy;trexate, azathioprine, mycophenolate mofetil, cyclosporine, and biologic agents such as infliximab, adalimumab, rituximab, and anakinra. Immunologic agents, most commonly intravenous or oral cyclophosphamide, can be added for necrotizing disease and refractory cases.</p>\n<p>For necrotizing scleritis, exploration and debridement with tectonic patch grafting may be necessary for severe thinning or perforation.</p>\n<p><strong>Peripheral Ulcerative Keratitis</strong></p>\n<p>Peripheral ulcerative keratitis (PUK) is a type of corneal melt that occurs when immune complexes infiltrate the vascular arcades in the 0.5-mm corneal periphery. RA is the most common etiology, accounting for 34% of cases; however, it can also be caused by other autoimmune, infectious, neurologic, and dermatologic conditions.5 In the setting of severe RA, PUK is usually accompanied by other ocular manifes&shy;tations, and it can occur secondary to scleritis, especially necrotizing scleritis.</p>\n<p>Characteristics. PUK presents with stromal thinning and a secondary overlying epithelial defect and is char&shy;acterized by neovascularization of the corneal periphery and crescent-shaped juxtalimbal ulcers. 5 It is uni&shy;lateral 60% of the time.1 It can present with pain, photophobia, tearing, and decreased visual acuity due to astigma&shy;tism or corneal opacity.</p>\n<p>The differential diagnosis includes Mooren ulcer, Terrien marginal de&shy;generation, herpetic keratitis, corneal ulcer secondary to dry eye, phlyctenular ulcers, and marginal keratitis. Corneal perforation is a feared complication.</p>\n<p><strong>PUK</strong></p>\n<p>PUK. Crescent-shaped ulcers are juxtaposed against the limbus.</p>\n<p>Other considerations. Like necro&shy;tizing scleritis, PUK is associated with increased mortality in patients with RA, and it can be a sign of impending systemic vasculitis.</p>\n<p>Treatment. The treatment strategy should prioritize management of the underlying RA. Systemic corticosteroids with or without immunologic agents are the mainstay of treatment. These agents may include oral mycophenolate mofetil, methotrexate, azathioprine, leflunomide, infliximab, adalimumab, or rituximab. Oral cyclosporine can be used if there is no underlying systemic vasculitis. Oral cyclophosphamide can be used in cases unresponsive to treat&shy;ment, while etanercept is less effective.</p>\n<p>Ocular support. Additional mea&shy;sures to help protect the cornea include topical medroxyprogesterone and acetylcysteine, which act as collagenase inhibitors, and oral tetracycline, which inhibits matrix metalloproteinase.</p>\n<p>Treating coexisting dry eye syn&shy;drome can bolster the tear film to conserve corneal integrity and prevent keratolysis. However, topical steroids can increase risk of perforation and should be avoided.2 Tissue adhesives such as cyanoacrylate glue; amniotic membrane; bandage contact lenses; and tectonic, lamellar, or penetrating keratoplasty can be used to prevent and manage perforation.</p>\n<p>Although controversial, perilimbal conjunctival resection may remove the immune complexes at their entry point into the cornea.</p>\n<ul>\n<li><strong>Scleromalacia perforans</strong> is a severe, <strong>painless, necrotizing</strong> form of <strong>scleritis</strong> associated with <strong>long-standing rheumatoid arthritis (RA)</strong>.</li>\n<li><strong>Clinical Features:</strong>\n<ul>\n<li>Gradual <strong>thinning of the sclera</strong> without inflammation</li>\n<li><strong>Painless perforation</strong> of the sclera (without uveal prolapse)</li>\n<li><strong>No significant congestion or redness</strong></li>\n<li><strong>Bluish appearance</strong> due to the underlying uvea showing through</li>\n</ul>\n</li>\n<li><strong>Strongly associated with autoimmune diseases</strong>, especially <strong>seropositive RA</strong>.</li>\n</ul>\n<p><strong>Incorrect Options Explanation:</strong></p>\n<ul>\n<li><strong>(A) Ciliary Staphyloma:</strong>\n<ul>\n<li><strong>Localized scleral thinning</strong> in the ciliary body region with <strong>uveal bulging</strong>.</li>\n<li>Seen in <strong>uveitis or trauma</strong>, but not typically in <strong>RA</strong>.</li>\n</ul>\n</li>\n<li><strong>(C) Coloboma:</strong>\n<ul>\n<li>Congenital defect due to <strong>incomplete closure of the embryonic fissure</strong>.</li>\n<li>Characterized by <strong>iris or choroidal defects</strong>, typically <strong>inferonasal</strong>, not related to RA.</li>\n</ul>\n</li>\n<li><strong>(D) Staphyloma:</strong>\n<ul>\n<li><strong>Ectasia of the uveal tissue</strong> through a weak scleral area due to <strong>high myopia, inflammation, or trauma</strong>.</li>\n<li>Unlike scleromalacia perforans, it is <strong>not painless and is associated with inflammation</strong>.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Scleromalacia perforans is a painless, progressive scleral thinning condition strongly linked to rheumatoid arthritis. It lacks inflammation and presents with a bluish discoloration due to uveal visibility.</strong></p>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">keratoconus</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">keratoglobus</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Vogt's Limbal girdle</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Corneal dystrophy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">For what condition is this surgery as shown in picture, done for?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202504213f37d2b7-d466-4b96-9c4d-553964f59288.jpg\"></span></p>",
      "unique_key": "DT1323528",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323528,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Corneal thinning disorders often lead to protrusion, irregular astigmatism, and in rare cases to corneal perforation. Pellucid Marginal Degeneration (PMD), and Keratoglobus do not have a known cause and eye rubbing is nowadays recognized as one of the major risk factor of keratoconus. In addition, corneal ectasia can also be acquired after LASIK (Laser Assisted In Situ Keratomileusis) procedure when LASIK is performed on preoperative unrecognized abnormal cornea. Corneal ectatic disease may impair vision which can be restored by optical means such as glasses, soft, or rigid gas permeable contact lenses. However, severe cases may require correction or restoration of tectonic integrity of the cornea by surgical means. Penetrating Keratoplasty (PKP) was for long time the treatment of choice then replaced by Deep Anterior Lamellar Keratoplasty (DALK). Although PKP and DALK can be very successful in this subset of patients, limitations can include high post-op cylinder, side effects from chronic topical steroids and corneal rejection. Intracorneal ring segments are another modality in the treatment of corneal ectactic disorders.</p>\r\n<p><strong>Introduction and Mechanism of Action:</strong></p>\r\n<p>In 1987, intrastromal rings were introduced as synthetic, intracorneal implants for the correction of various degrees of myopia. An elastic modulus, or modulus of elasticity, is the mathematical description of an object's or substance's tendency to be deformed elastically (i.e., nonpermanently) when a force is applied to it. In keratoconus, the corneal elastic modulus is reduced due to pathology in the corneal stroma. From a biomechanical perspective, the resistance to deformation is reduced in relation to the reduction of the elastic modulus that leads to increased strain and protrusion in the cornea. The consequence is increased curvature and corneal thinning, the hallmarks of keratoconus. Since stress is defined as applied force divided by cross-sectional area, stress focally increases in the zone of corneal thinning</p>\r\n<p>Intrastromal corneal ring segments (ICRSs) are placed in the mid-corneal peripheral stroma at approximately two-thirds of depth outside the central optical zone to reshape the anterior corneal surface while maintaining the prolate profile (positive asphericity) of the cornea. Intracorneal ring segment acts as spacer elements between the bundles of corneal lamellae producing a shortening of the central arc length (arc shortening effect) that is proportional to the thickness of the device. As a consequence of this effect, the central portion of the anterior corneal surface tends to flatten  and the peripheral area adjacent to ring insertion is displaced forward. Corneal changes induced by the ICRS must be in relation to the structural properties of the collagen framework in the corneal stroma. The stroma accounts for 90% of corneal thickness, and evidently its mechanical properties define for the most part the mechanical properties of the whole corneal structure.</p>\r\n<p>According to Barraquer, when material is removed from the central area of the cornea or added to the periphery, a central flattening effect is achieved. In contrast, when material is added to the center or removed from the corneal periphery, the central surface curvature is steepened. The corrective results vary in direct proportion to the thickness of the implant and in inverse proportion to its diameter. The thicker and smaller the device, the higher the refractive result achieved. The diameter of the ring is proportionally inverse to the flattening intensity. Thus, the smaller the diameter, the more tissue is added (ring thickness) with higher myopic correction.</p>\r\n<p>ICRS create an arc-shortening effect on the corneal lamellae, flattening the central cornea. For the correction of astigmatism, the end point of each segment may produce a traction force on the surface, producing additional flattening on this reference axis. In addition, the presence of a corneal inlay may provide biomechanical support for this ocular tissue. Topographic interpretation of eyes that underwent ICRS implantation shows overall flattening of the cornea, dislocation of the corneal apex towards the center, preservation of corneal asphericity, and decreased surface irregularity. ICRS change the arc length of the anterior corneal curvature. The refractive effect achieved is directly related to the thickness of the segments. Placing the ring segments in the periphery of the cornea causes local separation of the corneal lamellae which results in shortening of the corneal arc length. This flattening  effect on the cornea&shy; reduces myopia by lowering its optical power. Increasing the thickness of ICRS also causes greater degrees of local separation and increased corneal flattening. Thus, the degree of corneal flattening (correction) achieved by ICRS is directly related to their thickness.</p>\r\n<p>The initial enthusiasm regarding ICRS for the correction of myopia has faded for multiple reasons, including a limited range of correction, induced astigmatism, and slow visual recovery. Nowadays, the use of ICRS has evolved into an important therapeutic intervention for corneal ectatic diseases such as keratoconus and post-laser surgery-induced ectasia. Redistribution of corneal curvature leads to a redistribution of corneal stress, interrupting the biomechanical cycle of keratoconus disease progression, in some cases.</p>\r\n<p><strong>Incorrect Options:</strong></p>\r\n<ul>\r\n<li><strong>(B) Keratoglobus:</strong>\r\n<ul>\r\n<li>A rare, congenital, bilateral corneal ectasia causing <strong>global corneal thinning</strong>.</li>\r\n<li><strong>ICRS is NOT the treatment of choice</strong>; scleral contact lenses or lamellar keratoplasty may be considered.</li>\r\n</ul>\r\n</li>\r\n<li><strong>(C) Vogt&rsquo;s Limbal Girdle:</strong>\r\n<ul>\r\n<li>A <strong>benign, age-related corneal degeneration</strong> causing a white, arc-like deposit at the limbus.</li>\r\n<li>No treatment is required, as it does not affect vision.</li>\r\n</ul>\r\n</li>\r\n<li><strong>(D) Corneal Dystrophy:</strong>\r\n<ul>\r\n<li>A group of <strong>genetically inherited corneal disorders</strong> (e.g., Fuchs' dystrophy, lattice dystrophy).</li>\r\n<li>ICRS is <strong>not used</strong> in corneal dystrophies; instead, treatment may include endothelial keratoplasty or penetrating keratoplasty.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Intrastromal Corneal Ring Segments (ICRS) are primarily used to treat keratoconus by flattening the cornea and reducing irregular astigmatism.</strong> They help improve vision in patients who cannot tolerate contact lenses and may delay or prevent the need for corneal transplantation.</p>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Trauma</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Uveitis</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Leucoma</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudoexfoliation syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Spot the diagnosis<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250421be40dd21-fb3a-4eae-b494-dc05b080f71f.jpg\"></span></p>",
      "unique_key": "DT1323529",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323529,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Diagnosis of pex</p>\r\n<p>Diagnosis is made using slit lamp biomicroscopy and intraocular pressure measurement. Deposition of white fluffy material on the anterior lens capsule and pupillary margin and iris transillumination defects can be visualized in many cases. Gonioscopy may show increased pigment deposit on the trabecular meshwork.</p>\r\n<p>Physical examination</p>\r\n<p>Signs</p>\r\n<p>Increased intraocular pressure</p>\r\n<p>Possible glaucomatous damage to optic nerve</p>\r\n<p>Poor dilation with peripupillary transillumination defect</p>\r\n<p>Fibrillar white flaky deposits on the anterior lens capsule (Hoarfrost Ring)</p>\r\n<p>Fibrillar white flaky deposits on at pupillary border</p>\r\n<p>Hyperpigmentation of the trabecular meshwork (TM) with an open angle on gonioscopy</p>\r\n<p>Sampaolesi line, abundance of linear pigment anterior to the TM at or anterior to Schwalbe's line (not pathogonomic; also seen in pigment dispersion syndrome)</p>\r\n<p>Symptoms</p>\r\n<p>No associated symptoms aside from possibly with significantly increased intraocular pressure</p>\r\n<p><strong>Pseudoexfoliation Syndrome (PEX)</strong></p>\r\n<ul>\r\n<li>Characterized by <strong>white flaky deposits</strong> on the anterior lens capsule and pupillary border.</li>\r\n<li>Associated with <strong>poor pupillary dilation, trabecular hyperpigmentation, and increased intraocular pressure</strong>, leading to secondary glaucoma.</li>\r\n<li>Diagnosed using <strong>slit lamp biomicroscopy and gonioscopy</strong>.</li>\r\n</ul>\r\n<p><strong> Incorrect Options:</strong></p>\r\n<ul>\r\n<li><strong>A - Trauma:</strong> Would present with corneal edema, hyphema, or iris damage, not flaky deposits.</li>\r\n<li><strong>B - Uveitis:</strong> Typically presents with <strong>cells in the anterior chamber, photophobia, and pain</strong>, not white deposits.</li>\r\n<li><strong>C - Leucoma:</strong> Refers to a <strong>corneal opacity (scarring)</strong>, not anterior lens capsule changes.</li>\r\n</ul>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Pseudoexfoliation syndrome is an <strong>important cause of secondary glaucoma</strong> and can be identified by <strong>white fibrillar deposits on the lens and pupillary margin with trabecular hyperpigmentation</strong> on gonioscopy.</p>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin K</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which vitamin deficiency produces this kind of picture?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250421ae64961f-e5e3-48ac-a013-831737fa1643.jpg\">\r\n\r\n</span></p>",
      "unique_key": "DT1323530",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323530,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>xerophthalmia refers to the spectrum of ocular disease caused by severe Vitamin A deficiency (VAD). Vitamin A serves several essential functions in the eye, and deficiency can lead to a constellation of ocular signs and symptoms that affect the conjunctiva, cornea, and retina. Xerophthalmia continues to be a leading cause of preventable blindness in developing countries. Unfortunately, xerophthalmia signifies a severity of VAD that causes significant morbidity and mortality from malnutrition and increased susceptibility to mucosal infections.</p>\r\n<p><strong>Diagnosis</strong></p>\r\n<p><strong>Clinical Signs</strong></p>\r\n<p>Night blindness (Grade XN): Defective vision in dim light or night blindness is one of the most common manifestations of VAD, especially in children age 2-6 or pregnant or lactating women. Although it is considered one of the earliest manifestations, children with VAD may develop one of the more severe signs, such as corneal ulcers, after infection or diarrhea without any of the classically early signs. Children may not be able to verbalize their symptoms, and parents need to be asked if they have noticed their children behaving differently in the dark, e.g. becoming less active or fearful. Night blindness is considered to be both a sensitive and specific indicator for serum retinol levels.</p>\r\n<p>Conjunctival xerosis (Grade X1A): Conjunctival xerosis is characterized by a dull and dry appearance of the conjunctiva with slight wrinkling. It is caused by the loss of goblet cells and insufficient mucin secretion, and it can be subtle and difficult to detect clinically.</p>\r\n<p>Bitot spots (Grade X1B): Bitot spots are collections of desquamated, keratinized epithelial cells mixed with the gas-forming bacteria Corynebacterium xerosis. They appear as triangular patches of foamy, whitish, opaque deposits, typically located on the bulbar conjunctiva near the limbus at the 3 and 9 o&rsquo;clock positions. They are more common temporally.</p>\r\n<p>Severe corneal xerosis progressing to keratomalacia. Credit: EyeRounds.org, The University of Iowa. Reprinted without modification from an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.</p>\r\n<p>Corneal xerosis (Grade X2): Conjunctival xerosis is characterized by a dull and hazy appearance of the cornea that is caused by drying of the cornea secondary to conjunctival gland dysfunction. It may initially present with bilateral punctate corneal epithelial erosions, and it can quickly progress to the stage of corneal ulceration. Up to this stage, high-dose Vitamin A supplementation can result in the full preservation of vision.</p>\r\n<p>Corneal ulceration (Grade X3A and B): Corneal xerosis can lead corneal ulceration and melting if not treated urgently. Keratomalacia, the melting away of the cornea by liquefactive necrosis, is the most severe form of xerophthalmia. It can perforate and destroy the cornea in just a matter of days. A child who appears relatively healthy but develops keratomalacia should be questioned about a recent history of measles or diarrhea, which could rapidly deplete already deficient vitamin A stores.</p>\r\n<p>Corneal scar (Grade XS): Corneal scarring due to VAD is often symmetric and bilateral. Other causes of corneal scarring must be ruled out.</p>\r\n<p>Xerophthalmic fundus (Grade XF): prolonged VAD can lead to structural changes in the retina. Fundus changes appear as small, white, deep retinal lesions scattered throughout the posterior pole.</p>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute anterior uveitis</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic anterior uveitis</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Pars planitis</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Pan Uveitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient comes with a history of penetrating trauma and a diagnosis of sympathetic ophthalmitis was made. Which of the following will be seen?</span></p>",
      "unique_key": "DT1323531",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323531,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>disease Entity</strong></p>\r\n<p>Sympathetic ophthalmia (SO) is a rare, bilateral, granulomatous uveitis caused by exposure of previously immune-privileged ocular antigens from trauma or surgery with a subsequent bilateral autoimmune response to this tissue. The injured or operated eye is the exciting eye and the contralateral eye is the sympathizing eye. The concept was first described by Hippocrates and the earliest references can be traced back to the 1500s. It wasn't until the 1900s that an association with non-trauma-related ocular surgery was published and that a systemic autoimmune etiology was suspected. Several historical figures are hypothesized to have suffered from sympathetic ophthalmia, including Louis Braille, the inventor of modern Braille. His right eye was injured at the age of 3 when he was playing with a knife, and he subsequently lost vision in both eyes by the age of 5, presumably from sympathetic ophthalmia.</p>\r\n<p><strong>Etiology and Epidemiology</strong></p>\r\n<p>Prior trauma and introacular surgery are the causes of SO. A growing list of procedures has been associated with this disease and virtually any intraocular event can incite the autoimmune process. Vitrectomy and cyclodestructive procedures have been associated with potentially higher rates and some authors suggest specifically discussing the risk of sympathatic ophthalmia during informed consent. The interval between the time of injury and the onset of symptoms is variable and has been reported to be from 5 days to 66 years, although the vast majority of cases occur within the first several years. Due to the rarity of the disease, variable presentation and potentially long duration between inciting event and disease process, the epidemiology of sympathetic ophthalmia remains poorly understood.</p>\r\n<p><strong>Pathology </strong></p>\r\n<p>Note the diffuse, granulomatous inflammation of the choroid with sparing of the choriocapillaris.</p>\r\n<p>The injured eye is the exciting eye and the fellow eye is known as the sympathizing eye. The primary inlfammatory mediators are thought to be T cells that invade the uveal tract. Studies have shown that an initial wave of infiltrative cells is composed of CD4+ helper T cells and a later wave of CD8+ cytotoxic T cells. Furthermore, in vitro testing has shown proliferative T cell responses to uveal melanocytes in the peripheral blood of patients with sympathetic ophthalmia. The inflammation is usually granulomatous and the choroid is diffusely thickened with lympochytes, nests of epithelioid cells and multinucleated giant cells. The epithelioid cells and giant cells often contain melanin pigment. The inflammatory process does not usually involve the choriocapillaris (in contrast to Voyt-Koyanagi-Harada syndrome) or the retina. Dalen-Fuchs nodules, which are clusters of epithelioid cells containing pigment lying between the RPE and Bruchs membrane, are also seen. Anteriorly, the iris can appear thickened with nodular infiltrations.</p>\r\n<p><strong>Prevention</strong></p>\r\n<p>There has been debate regarding the only known means of preventing sympathetic ophthalmia, i.e. removal of the injured eye shortly after the traumatizing event. The goal of enucleation or evisceration is to prevent exposure of uveal and retinal tissue to the immune system. Enucleation has historically been then treatment modality of choice out of concern that evisceration might leave behind residual uveal tissue. However, an evisceration is easier and quicker to perform, and arguably has better functional and cosmetic results. To support the argument that evisceration is a viable alternative are case series of positive outcomes. Also, the logical argument that since evisceration is a viable treatment option in non-trauma-causes, then the uveal tissue left behind on routine, non-trauma-related eviscerations likely isn't sufficient to promote a SO response; otherwise, one would expect higher rates of SO following all eviscerations. Finally, some authors argue against removing the eye because of the rarity of SO and the effective modern treatment options. Also, the exciting eye may also have useful vision after therapy. There is no known benefit to removing the exciting eye after the onset of sympathetic ophthalmia.</p>\r\n<p><strong>Diagnosis</strong></p>\r\n<p><strong>Symptoms</strong></p>\r\n<p>Patients typically present with non-specific symptoms of ocular inflammation, including blurred or decreased vision, pain, photophobia and conjunctival injection. Typically, reduction of near vision is an early symptom. The onset can be insidious or acute. A thorough ocular history plays an important role in the diagnosis of sympathetic ophthalmia as the patient will have a history of trauma or surgery, either recently or in the remote past. Evidence of prior trauma on examination can also aid in the diagnosis of SO when history is incomplete.</p>\r\n<p><strong>Clinical evaluation </strong></p>\r\n<p>This fundus image of a patient with sympathetic ophthalmia demonstrates vitritis and a multifocal choroiditis.</p>\r\n<p>Sympathetic ophthalmia is characterized by inflammation involving any part and most of the uveal tract. Anterior segment findings include keratic precipitates, anterior chamber reaction, posterior synechiae and the development of a cataract. In eyes with chronic inflammation, either elevated pressures from inflammatory glaucoma or hypotony from ciliary body shutdown can develop. Posteriorly, patient can develop vitritis, papillitis, multifocal choroiditis, Dalen-Fuchs nodules, multiple exudative retinal detachments, macular edema, choroidal neovascularization and epiretinal membranes. In severe cases, the eye can become phthisical. The exciting eye, if still present, may show evidence of prior surgery or injury and can steer the clinician to suspect SO. Patients may also have systemic findings. In a large retrospective study out of China, 24% of patients with SO had meningismus, 25% tinnitus, 20% dysacusis, 13% alopecia and 11% poliosis. Only retinitis and retinal vasculitis are not typically seen in SO.</p>\r\n<p><strong>Ancillary procedures</strong></p>\r\n<p>Optical Coherence Tomography (OCT) can be utilized to evaluate and follow serous retinal detachments. OCT can also help monitor for macular edema and the developement of choroidal neovascularization. Enhanced depth OCT can dentify pachychoroid. Disruption of the interdigitation zone (IZ) and ellipsoid zone (EZ) on OCT may precede clinical signs of uveitis. The underlying retinal pigmented epithelium is typically not straight and usually have undulations or convexity towards the retina. Typically, miltifocal pockets of subretinal fluid are noted. Bacillary layer detachment as seen in Vogt Koyanagi Harada disease may also be noted.</p>\r\n<p>Fluorescein angiography can show multiple areas of pinpoint hyperfluorescence, which leak on later phases in areas that correspond to the serous retinal detachments seen clinically.</p>\r\n<p><strong>Differential diagnosis</strong></p>\r\n<p>The most common alternate diagnosis is Vogt-Koyanagi-Harada syndrome (VKH). Patients with VKH lack a history of antecedent trauma, have higher rates of systemic findings and also typically follow the pattern of early posterior findings with later anterior inflammation. Other diagnoses on the differential include tuberculosis, syphilis and depending on the presentation, numerous other causes of inflammation. The infectious causes of uveitis must be ruled out prior to initiating treatment for sympathetic ophthalmia due to the risk of worsening the underlying infection with immunosuppression.</p>\r\n<p><strong>Management</strong></p>\r\n<p>Corticosteroids are the mainstay of treatment. Steroids should be initiated as soon as the diagnosis is made in the absence of other contraindications and once infectious workup is negative. In acute stage, intravenous methylprednisolone pulse therapy reduces the posterior segment changes rapidly.</p>\r\n<p>Along with corticosteroids, immunomodulators such as cyclosporine or azathioprine should be used. SO is one of the few indications where immunomodulatory therapy should be started at the initial presentation only.</p>\r\n<p>Patients should be followed closely and may need to be admitted if they cannot follow up or take the medications as prescribed. Patients should be seen often until they begin to stabilize and improve at which point visits can be spread out.</p>\r\n<p><strong>Prognosis</strong></p>\r\n<p>Sympathetic Ophthalmia is a serious vision-threatening disease. Half of all patients will have 20/40 or worse vision and one third of all patients will end up legally blind. However, with modern therapy, there is plenty of hope for patients diagnosed with this disease. Even the exciting eye can have reasonable visual outcome with prompt and aggressive treatment.</p>\r\n<p><strong>Incorrect Options:</strong></p>\r\n<ul>\r\n<li><strong>A - Acute Anterior Uveitis:</strong> Limited to the anterior chamber, presents with <strong>cells and flare</strong>, but sympathetic ophthalmitis is <strong>granulomatous and pan uveitic</strong>.</li>\r\n<li><strong>B - Chronic Anterior Uveitis:</strong> Also confined to the anterior chamber; however, <strong>sympathetic ophthalmitis is more extensive</strong>.</li>\r\n<li><strong>C - Pars Planitis:</strong> A form of <strong>intermediate uveitis</strong>, characterized by <strong>vitritis and snowbanking</strong>, not associated with trauma.</li>\r\n</ul>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Sympathetic ophthalmitis is a <strong>sight-threatening, bilateral, granulomatous pan uveitis</strong> that occurs <strong>after penetrating trauma</strong> and requires <strong>prompt systemic corticosteroids or immunosuppression</strong>.</p>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Gaucher's disease</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Tay sach disease</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Hunter's disease</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Hurler's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with mental retardation and a cherry red spot. What is the diagnosis?</span></p>",
      "unique_key": "DT1323532",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323532,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250421907bae2b-c105-420b-8e8c-b73340982a45.jpg\">",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Pan retinal photocoagulation\r\n</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Grid retinal photocoagulation</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Focal retinal photocoagulation</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti VEGF drugs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A diabetic patient comes to you with preretinal haemorrhages and neovascularization of disc. What is the treatment?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250421746ed943-669e-40ee-b724-054621c4a7f6.jpg\"></span></p>",
      "unique_key": "DT1323533",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323533,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250421e5f93e03-38ef-4b53-99af-7d5388921fb6.jpg\"><br><p>Panretinal photocoagulation (PRP) or cryoapplication, if the media is hazy, may be required to prevent neovascular glaucoma in patients with widespread capillary occlusion.</p>\r\n<p>Photocoagulation should be carried out when most of the intraretinal blood is absorbed, which usually takes about 3-4 months.</p>\r\n<p>100-day glaucoma or NVG results from conditions which lead to neovascularization in the eye eg. PDR, CRVO, Retinal malignancies and rarely in CRAO.</p>\r\n<p>There are two facets of diabetes: diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR).</p>\r\n<p>DME can be treated medically with steroids (triamcinolone, dexamethasone, fluocinolone, etc.) and anti-VEGFs (both FDA and non-FDA approved), including ranibizumab (Lucentis, Genentech), bevacizumab (Avastin, Genentech), and aflibercept (Eylea, Regeneron). It can also be treated with focal laser.</p>\r\n<p>For PDR, we have medical treatment, which consists mostly of anti-VEGFs, and laser treatment, consisting of panretinal photocoagulation (PRP).</p>\r\n<p>DRCR PROTOCOLS</p>\r\n<p>Let&rsquo;s take a quick look at the Diabetic Retinopathy Clinical Research (DRCR) network protocols.</p>\r\n<p>Protocol I compared ranibizumab and focal laser (either immediate or delayed) treatment versus focal laser, and steroids versus just focal laser alone for DME. Ranibizumab maintained the letter gain over the other groups.</p>\r\n<p>Protocol S was slightly more controversial, but it pitted ranibizumab versus PRP for PDR. Ranibizumab was noninferior, so it at least gave us another weapon to use for PDR other than laser, perhaps with less visual field loss.</p>\r\n<p>Protocol T was a comparison of all the anti-VEGFs-ranibizumab, bevacizumab, and aflibercept. At 1 year, aflibercept was better for vision gain, if the vision was 20/50 or worse, but that difference disappeared at 2 years between aflibercept and ranibizumab. Bevacizumab never caught up.</p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic\r\n</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Oculomotor</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Trigeminal</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Abducens</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient comes to you with photophobia, lacrimation and headache which nerve is affected?\r\n</span></p>",
      "unique_key": "DT1323534",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323534,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The trigeminal nerve can be daunting when it comes to studying its anatomy. It has many functions, and even though it possesses only three major branches, each one of them is highly important and anatomically complex.</p>\r\n<p>The ophthalmic nerve is one of the branches of the trigeminal nerve, otherwise known as the fifth cranial nerve (CN V). Supplying sensory innervation to certain parts of the eye, the lacrimal gland, some paranasal sinuses, meningeal layers, and the scalp this nerve allows you to blink quickly when dust gets in the eye,</p>\r\n<p>The ophthalmic nerve arises from the anterior edge of the trigeminal ganglion and then extends forward through the lateral wall of the dura mater of the cavernous sinus. Superior to the ophthalmic nerve is the trochlear nerve, whereas inferolateral to it is the maxillary nerve. Medial to all of these three nerves is located the internal carotid artery that goes through the cavernous sinus.</p>\r\n<p>After leaving the cavernous sinus, the ophthalmic nerve goes through the superior orbital fissure, where it is usually already divided into its three terminal branches:</p>\r\n<p>Lacrimal nerve</p>\r\n<p>Frontal nerve</p>\r\n<p>Nasociliary nerve</p>\r\n<p>Damages to the ophthalmic nerve can cause symptoms related to sensory dysfunctions. Infections of the trigeminal ganglion by the herpes zoster virus (shingles) will cause very painful sensations among all of the areas that are sensory innervated by the trigeminal nerve, but will mostly affect the areas innervated by the ophthalmic nerve. The infection may eventually result in the complete loss of the sensation within the affected parts.</p>\r\n<p>A procedure called supraorbital nerve block is often used to achieve the local anesthesia of the face. As the name says for itself, the target structure is the supraorbital nerve, a branch of the frontal nerve, which again, is a terminal branch of the ophthalmic nerve. It is a convenient way of preventing the tissue distortion and the uncomfortable sensations for the patient while performing various surgical procedures in the region of the forehead that is innervated by this nerve.</p>\r\n<p>Dysfunctions of the ophthalmic nerve can be joined to the dysfunctions of the facial nerve within the condition called Bell&rsquo;s palsy. This condition mostly affects the structures innervated by the facial nerve and sometimes includes branches of the trigeminal nerve where sensory disorders of all the structures innervated by this nerve can manifest. This condition is usually caused by the inflammation of the nerve that is in most cases caused by neurotropic viruses, such as herpes simplex virus type-1, HIV, and herpes zoster.</p>\r\n<p>The ophthalmic nerve is a part of the corneal reflex, and together with the maxillary nerve, the palpebral reflex. In normal situations, the stimulation of the cornea or a sudden object close to the eyes will cause automatic closing of the eyelids as a form of a protective reflex. When the ophthalmic nerve is damaged, there is a lack of these reflexes.</p>\r\n<p><strong>Incorrect Options:</strong></p>\r\n<ul>\r\n<li><strong>A - Optic Nerve (CN II):</strong> Involved in <strong>vision</strong>, not pain sensation; damage causes <strong>visual loss</strong>, not photophobia or lacrimation.</li>\r\n<li><strong>B - Oculomotor Nerve (CN III):</strong> Controls <strong>extraocular muscles and pupil constriction</strong>, but not <strong>sensory functions</strong>.</li>\r\n<li><strong>D - Abducens Nerve (CN VI):</strong> Controls the <strong>lateral rectus muscle</strong> for eye movement; dysfunction leads to <strong>diplopia</strong>, not sensory symptoms.</li>\r\n</ul>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>The <strong>trigeminal nerve (CN V)</strong>, specifically the <strong>ophthalmic division (V1)</strong>, is responsible for <strong>corneal sensation, photophobia, lacrimation, and headaches</strong> due to its role in <strong>pain transmission from the eye and surrounding structures</strong>.</p>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}